These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19340405)

  • 1. [Treatment of lingual dystonia with botulinum toxin injections. First report].
    Reichel G; Stenner A
    Nervenarzt; 2009 Aug; 80(8):959-62. PubMed ID: 19340405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.
    Yoshida K
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.
    Nastasi L; Mostile G; Nicoletti A; Zappia M; Reggio E; Catania S
    J Neurol; 2016 Sep; 263(9):1702-8. PubMed ID: 27278063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin injections for lingual dystonia.
    Blitzer A; Brin MF; Fahn S
    Laryngoscope; 1991 Jul; 101(7 Pt 1):799. PubMed ID: 2062167
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidisciplinary management of a partially edentulous patient with oromandibular dystonia: A clinical report.
    Sakar O; Matur Z; Mumcu Z; Sesen P; Oge E
    J Prosthet Dent; 2018 Aug; 120(2):173-176. PubMed ID: 29429838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lingual protrusion dystonia: Manifestation during "on" periods in Parkinson's disease.
    Maiola R; Ramirez Gómez CC; Micheli F
    J Neurol Sci; 2016 Nov; 370():256-257. PubMed ID: 27772770
    [No Abstract]   [Full Text] [Related]  

  • 8. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.
    Hennings JM; Krause E; Bötzel K; Wetter TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
    Adler CH; Factor SA; Brin M; Sethi KD
    Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare case of laryngeal dystonia associated with neurosyphilis: Response to botulinum toxin injection.
    Ho KH; Wright CC; Underbrink MP
    Laryngoscope; 2011 Jan; 121(1):147-9. PubMed ID: 21154825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of dystonia occurring in parkinsonian syndromes by botulinum toxin.
    Limousin P; Memin B; Pollak P
    Eur Neurol; 1997; 37(1):66-7. PubMed ID: 9018038
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report.
    Vazquez-Delgado E; Okeson JP
    Cranio; 2004 Oct; 22(4):325-9. PubMed ID: 15532318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of botulinum toxin A in the treatment of focal dystonias].
    Sławek J; Duzyński W
    Neurol Neurochir Pol; 1997; 31(2):207-15. PubMed ID: 9380251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin for foot dystonia in patients with Parkinson's disease having deep brain stimulation: A case series and a pilot study.
    Gupta AD; Visvanathan R
    J Rehabil Med; 2016 Jun; 48(6):559-62. PubMed ID: 27122065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injection for the treatment of oromandibular dystonia.
    Blitzer A; Brin MF; Greene PE; Fahn S
    Ann Otol Rhinol Laryngol; 1989 Feb; 98(2):93-7. PubMed ID: 2916831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tibialis anterior tendinopathy in a dystonic talipes calcaneovarus foot: A case treated by botulinum toxin.
    Sturbois-Nachef N; Kozlowski O; Benoit A; Fontaine C; Allart É
    Ann Phys Rehabil Med; 2019 Jan; 62(1):60-63. PubMed ID: 30053629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.